Literature DB >> 1101819

Relation of beta-lactamase activity to antimicrobial susceptibility in Serratia marcescens.

J C Tsang, G A Sansing, M A Miller.   

Abstract

One-hundred clinical isolates of Serratia marcescens were tested for susceptibility to cephalothin, carbenicillin, ticarcillin, ampicillin, and cefoxitin. The majority of the 100 isolates (>/=70%) were susceptible to carbenicillin, ticarcillin, and cefoxitin; less than one-half were susceptible to ampicillin; none were susceptible to cephalothin. Ten isolates from the 100 organisms tested were selectively assayed for their beta-lactamase activity. Enzyme activity was measured using either iodometric or spectrophotometric methods, and the microbiological assay technique. It was concluded that beta-lactamase production was not the sole determinant in beta-lactam antibiotic resistance. Resistance without demonstrable beta-lactamase was evident in strains for cephalothin, ampicillin, and cefoxitin. In addition, one strain which was susceptible to all antibiotics except cephalothin, elaborated considerable beta-lactamase activity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1101819      PMCID: PMC429306          DOI: 10.1128/AAC.8.3.277

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Antibiogram and lipid analysis of a pigmented strain of Serratia marcescens and its nonpigmented variants.

Authors:  G L Button; M A Miller; J C Tsang
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

2.  Antibiograms and lipid contents of pigmented and nonpigmented strains of Serratia marcescens.

Authors:  M A Miller; C Y Chang; J C Tsang
Journal:  Antimicrob Agents Chemother       Date:  1973-07       Impact factor: 5.191

3.  Numerical study of 60 strains of Serratia.

Authors:  P A Grimont; H L Dulong de Rosnay
Journal:  J Gen Microbiol       Date:  1972-09

4.  Beta-lactamase and the resistance of Pseudomonas aeruginosa to various penicillins and cephalosporins.

Authors:  N Garber; J Friedman
Journal:  J Gen Microbiol       Date:  1970-12

5.  Low magnesium and phospholipid content of cell wals of Pseudomonas aeruginosa resistant to polymyxin.

Authors:  M R Brown; W M Watkins
Journal:  Nature       Date:  1970-09-26       Impact factor: 49.962

6.  Comparison of the substrate specificities of the -lactamases from Klebsiella aerogenes 1082E and Enterobacter cloacae P99.

Authors:  M J Marshall; G W Ross; K V Chanter; A M Harris
Journal:  Appl Microbiol       Date:  1972-04

7.  Relationship Between beta-Lactamase Activity and Resistance of Enterobacter to Cephalothin.

Authors:  W E Farrar; J M Krause
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

8.  Lipid content of antibiotic-resistant and -sensitive strains of Serratia marcescens.

Authors:  C Y Chang; R E Molar; J C Tsang
Journal:  Appl Microbiol       Date:  1972-12

9.  Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation.

Authors:  H R Onishi; D R Daoust; S B Zimmerman; D Hendlin; E O Stapley
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

10.  Distribution of Serratia species in clinical specimens.

Authors:  E Johnson; P D Ellner
Journal:  Appl Microbiol       Date:  1974-09
View more
  5 in total

1.  Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae.

Authors:  J L Ott; J R Turner; D F Mahoney
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

Review 2.  Is it reasonable to use cephalosporins in respiratory and upper tract renal infections in hospitalized patients?

Authors:  R L Perkins
Journal:  Bull N Y Acad Med       Date:  1984-05

3.  Substrate inhibition of beta-lactamases, a method for predicting enzymatic stability of cephalosporins.

Authors:  D F Mahoney; G A Koppel; J R Turner
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

Review 4.  Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-01       Impact factor: 9.546

5.  Phenomenon of resistance to Augmentin associated with sensitivity to ampicillin: occurrence and explanation.

Authors:  W Brumfitt; J M Hamilton-Miller; S Dixson; R A Gargan; A Gooding
Journal:  J Clin Pathol       Date:  1983-06       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.